Mujeeb Shad

Associate Professor

  • 1294 Citations
  • 18 h-Index
19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 1294 Citations
  • 18 h-Index
  • 32 Article
  • 13 Letter
  • 5 Review article
  • 2 Chapter
Filter
Letter
2020

Is there an association between anxiety symptoms and valsartan treatment?

Shad, M. U., Jan 15 2020, In : Journal of Affective Disorders. 261, p. 111-112 2 p.

Research output: Contribution to journalLetter

2019

Aripiprazole-induced kleptomania: Case report

Jones, R. & Shad, M., Feb 1 2019, In : Journal of Affective Disorders. 244, p. 242-243 2 p.

Research output: Contribution to journalLetter

Can low-dose aripiprazole reverse some of the adverse effects from a long-acting injectable?

Fryefield, K. & Shad, M., Feb 1 2019, In : Schizophrenia Research. 204, p. 417-418 2 p.

Research output: Contribution to journalLetter

2017

Delayed galactorrhea after discontinuation of risperidone in a schizophrenia patient

Lenz, K., Perry-Rose, J. & Shad, M., Dec 1 2017, In : Asian Journal of Psychiatry. 30, p. 75-76 2 p.

Research output: Contribution to journalLetter

Hyperprolactinemia with low dose of risperidone in a young female

Boothby, A. & Shad, M., Jun 1 2017, In : Asian Journal of Psychiatry. 27, p. 69-70 2 p.

Research output: Contribution to journalLetter

2 Scopus citations
2012

Insight and empathy in schizophrenia

Didehbani, N., Shad, M. U., Tamminga, C. A., Kandalaft, M. R., Allen, T. T., Chapman, S. B. & Krawczyk, D. C., Dec 1 2012, In : Schizophrenia Research. 142, 1-3, p. 246-247 2 p.

Research output: Contribution to journalLetter

6 Scopus citations
2001

The economic consequences of a drug-drug interaction [8]

Shad, M. U., Marsh, C. & Preskorn, S. H., Feb 5 2001, In : Journal of clinical psychopharmacology. 21, 1, p. 119-120 2 p.

Research output: Contribution to journalLetter

30 Scopus citations
2000

Failure to consider drug-drug interactions as a likely cause of behavioral deterioration in a patient with bipolar disorder [5]

Shad, M. U., Preskorn, S. H. & Izgur, Z., Jun 6 2000, In : Journal of clinical psychopharmacology. 20, 3, p. 390-392 3 p.

Research output: Contribution to journalLetter

4 Scopus citations

Lack of sertraline efficacy probably due to an interaction with carbamazepine [1]

Khan, A., Shad, M. U. & Preskorn, S. H., Jan 1 2000, In : Journal of Clinical Psychiatry. 61, 7, p. 526-527 2 p.

Research output: Contribution to journalLetter

Open Access
15 Scopus citations
1999

Drug-drug interaction in reverse: Possible loss of phenytoin efficacy as a result of fluoxetine discontinuation [1]

Shad, M. U. & Preskorn, S. H., Oct 5 1999, In : Journal of clinical psychopharmacology. 19, 5, p. 471-472 2 p.

Research output: Contribution to journalLetter

5 Scopus citations
1998

Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome [4]

Shad, M. U. & Preskorn, S. H., Aug 11 1998, In : Journal of clinical psychopharmacology. 18, 4, p. 346-347 2 p.

Research output: Contribution to journalLetter

6 Scopus citations
1997

A possible bupropion and imipramine interaction [1]

Shad, M. U. & Preskorn, S. H., Apr 16 1997, In : Journal of clinical psychopharmacology. 17, 2, p. 118-119 2 p.

Research output: Contribution to journalLetter

31 Scopus citations

A possible pharmacokinetic interaction between fluoxetine and acetylsalicylic acid [4]

Shad, M. U., Harvey, A. T. & Lucot, J. B., Jan 1 1997, In : Journal of Clinical Psychiatry. 58, 12, p. 549-550 2 p.

Research output: Contribution to journalLetter

Open Access
2 Scopus citations